TickerSpark Feed

turnaround

Everything tagged "turnaround" across the TickerSpark archives.

Nike (NKE): Running Recovery vs. China Drag

Nike is in a difficult reset: Running is gaining traction, but weak Sportswear, a 17% China decline, and softer Direct sales keep the near-term outlook muted.

Oct 1, 2026·19 MIN

Consumer Cyclical Footwear & Accessories Consumer

Research ReportPSKY

Paramount Skydance (PSKY): Streaming Turnaround Faces Debt Risk

Paramount Skydance is showing real momentum in Paramount+ and Studios, but shrinking TV Media and a heavy debt load keep the turnaround high risk. The stock screens as a Hold with recovery upside if execution stays on track.

Oct 1, 2026·18 MIN

Communication Services Entertainment Media

Research ReportBA

Boeing (BA): Recovery Upside vs. Execution Risk

Boeing is showing real recovery momentum with higher deliveries, positive free cash flow, and a massive backlog, but profitability and leverage remain weak. The stock looks like a Hold as execution on certification, production, and margins will determine whether the turnaround sticks.

Sep 29, 2026·19 MIN

Industrials Aerospace & Defense Aerospace

Research ReportGME

GameStop (GME): Turnaround Profits vs. Execution Risk

GameStop has turned profitable with stronger margins and a cash-rich balance sheet, but the stock still hinges on collectibles growth and disciplined capital allocation. Hold reflects a healthier business offset by an uneven earnings outlook and a rich forward multiple.

Sep 26, 2026·20 MIN

Consumer Cyclical Specialty Retail Value

Research ReportAPOG

Apogee Enterprises (APOG): Recovery Upside at a Discount

Apogee Enterprises earns a Buy as backlog growth, Fortify savings, and Kalwall integration support a recovery story despite weaker Glass margins and softer earnings. The stock looks inexpensive relative to its earnings power and analyst target.

Sep 25, 2026·21 MIN

Industrials Building Products & Equipment Value

Research ReportKMX

CarMax (KMX): Turnaround Gains, But Valuation Capped

CarMax is showing better sales momentum and tighter costs, but earnings remain thin and the stock already reflects much of the turnaround. The report keeps KMX at Hold with a fair value of $58.

Sep 16, 2026·20 MIN

Consumer Cyclical Auto & Truck Dealerships Value

Research ReportSATS

EchoStar (SATS): Asset Monetization Over Growth

EchoStar is a high-risk asset monetization story with valuable spectrum and satellite assets, but declining subscribers, heavy leverage, and Hughes restructuring keep the stock in Hold territory.

Sep 11, 2026·17 MIN

Communication Services Telecom Services Value

Research ReportRH

RH (RH): Luxury Growth Meets Balance-Sheet Risk

RH is a differentiated luxury home-furnishings brand with a credible growth path through RH Estates, international galleries, and trade channels. The stock screens attractively on valuation, but leverage and weak liquidity keep execution risk high.

Sep 10, 2026·19 MIN

Consumer Cyclical Specialty Retail Luxury

Research ReportUNFI

United Natural Foods (UNFI): Turnaround Gains vs. Leverage

UNFI is showing clear profit and cash-flow improvement even as sales decline. The stock looks like a Hold as operational gains are offset by leverage and modest revenue growth.

Sep 8, 2026·21 MIN

Consumer Defensive Food Distribution Value

Research ReportCPB

Campbell’s (CPB): Turnaround Risks Outweigh Brand Strength

Campbell’s combines durable brands and cash generation with falling revenue, margin pressure, and a difficult Snacks turnaround. The report rates CPB a Hold as management works through a multi-year reset.

Sep 7, 2026·19 MIN

Consumer Defensive Packaged Foods Value

Research ReportTSN

Tyson Foods (TSN): Mix Shift Supports a Hold

Tyson Foods is a cyclical protein producer with improving mix, led by Chicken and Prepared Foods, but Beef losses and a rich valuation keep the stock at Hold.

Sep 3, 2026·21 MIN

Consumer Defensive Farm Products Value

Research ReportM

Macy's (M): Turnaround Gains Traction as Sales Improve

Macy's is showing real operational progress, with Q1 comparable sales up 3.0% and stronger performance at Bloomingdale's and Bluemercury. The stock remains a Buy as the Bold New Chapter strategy gains traction, though debt and uneven category trends still matter.